Abstract:Purpose/Objective: Although radiation therapy may play a role in the treatment of unresectable diffuse hepatocellular carcinoma, coexistence of cirrhotic pathology in the liver enhances the toxicity of liver irradiation. We have previously demonstrated that parenchymal liver cell transplantation ameliorates radiation-induced liver damage (RILD) in rats receiving partial hepatectomy (PH) and whole liver irradiation (WLI). Although hepatocyte transplantation has been used to “buy time” for patients with terminal liver disease awaiting whole liver transplantation, its role in ameliorating radiation injury in cirrhotic livers is unknown. In order to address this question, we first developed a rodent model of RILD in cirrhotic rat livers. Materials/Methods: Male F344 Rats received intraperitoneal injections (1 ml/kg of a 1% solution) of dimethylnitrosamine (DMN) three times per week for eight weeks. Animals were subjected to either laparotomy alone (sham RT, n=7), intraoperative WLI of 30 Gy (n=7) or 50 Gy (n=10). Separate groups of animals received 68% partial hepatectomy (PH) or PH+50Gy irradiation (n=5). Hepatic irradiation was delivered using a 320 MGC Philips orthovoltage unit operating at 320 kVP, 5mA and 0.5 mm Cu filtration (220 cGy/min hepatic exposure in the midline at 3 cm depth within the jig at 35 cm SSD). Liver function tests were performed monthly. Liver tissues were stained with hematoxylin and eosin, reticulin, and trichrome for histological assessment of hepatocellular morphology, cell death and fibrosis. Results: Pilot studies were performed to determine the optimal time course for DMN injection for induction of stable cirrhosis. Eight weeks of DMN injection induced cirrhotic changes in the liver that did not regress following DMN withdrawal. The survival of various groups of animals were as follows: (see Table). 1) Hepatic irradiation decreased survival of rats with established cirrhosis in a dose-dependent relationship. Survival of cirrhotic rats was reduced by 47% following 50 Gy of whole liver irradiation (Median survival time 49 days in 50Gy-treated rats versus 102 days in rats receiving no irradiation, p= 0.014). Control rats without cirrhosis, but treated with 50Gy were all alive at the same time period. Histological examination demonstrated marked disruption of hepatic architecture with bridging fibrous connective tissue septa. 2) Hepatic irradiation after PH (n=6) was highly lethal with a median survival of 2 days compared to 102.5 days in animals receiving PH alone (n=4). Liver function tests were highly elevated in these animals indicating acute decompensation of cirrhotic liver. Conclusions: We have established a rodent model for investigating the incidence of Radiation Induced Liver Damage (RILD) in cirrhotic livers, with demonstration of a dose response to varying doses of radiation. Further studies will be performed to investigate the role of hepatocyte transplantation in combination with radiation for the amelioration of RILD in cirrhotic livers. Tabled 1GroupsMean Survival ± SD (weeks)N (Total)P value (log-rank test)Sham RT13.1 ± 9.141030 Gy WLI8.6 ± 4.670.13 (vs. Sham)50 Gy WLI6.9 ± 2.790.014 (vs. Sham) 0.04 (vs 30 Gy) Open table in a new tab

Single Liver Lobe Repopulation with Wildtype Hepatocytes Using Regional Hepatic Irradiation Cures Jaundice in Gunn Rats

Hepatic Irradiation Augments Engraftment Of Donor Cells Following Hepatocyte Transplantation

[Treatment of Acute Liver Injury by Intrasplenic Transplantation of Hepatic Stem Cells Combined with Heparin in Rats].

Liver Regeneration and Energetic Changes in Rats Following Hepatic Radiation Therapy and Hepatocyte Transplantation by 31P MRSI

Co-Transplantation of Liver Sinusoidal Endothelial Cells Promotes Repopulation of Transplanted Hepatocytes Following Hepatic Irradiation

Radiation Induced Liver Damage (RILD) in a Cirrhotic Rat Model

HEPATOCYTE TRANSPLANTATION FOR ENZYME DEFICIENCY DISEASE IN CONGENIC RATS

Intrabiliary Infusion of Naked DNA Vectors Targets Periportal Hepatocytes in Mice

The Regenerative Effect of Portal Vein Injection of Liver Organoids by Retrorsine/Partial Hepatectomy in Rats

Hepatocyte regeneration after partial liver irradiation in rats

Survival-Assured Liver Injury Preconditioning (SALIC) Enables Robust Expansion of Human Hepatocytes in <i>Fah</i><SUP>-/-</SUP><i>Rag2</i><SUP>-/-</SUP><i>IL2rg</i><SUP>-/-</S UP> Rats

Hepatic regeneration after sublethal partial liver irradiation in cirrhotic rats.

Effect of donor strains and age of the recipient in the use of microencapsulated hepatocytes to control hyperbilirubinemia in the Gunn rat

Liver Xeno-Repopulation with Human Hepatocytes in Fah−/−Rag2−/− Mice after Pharmacological Immunosuppression

Noninvasive Evaluation of Liver Repopulation by Transplanted Hepatocytes Using 31P MRS Imaging in Mice.

Survival‐Assured Liver Injury Preconditioning (SALIC) Enables Robust Expansion of Human Hepatocytes in Fah –/– Rag2 –/– IL2rg –/– Rats

Allogeneic Liver Transplantation and Subsequent Syngeneic Hepatocyte Transplantation in a Rat Model: Proof of Concept for in vivo Tissue Engineering

Transplantation of bone marrow-derived hepatocyte-like cells via the portal vein in rat hepatic fibrosis models

Hepatic proliferation after partial liver irradiation in Sprague–Dawley rats

Transduction of Primary Rat Hepatocytes with Bicistronic Retroviral Vector

Therapeutic Effect of Transplanting Β2m−/thy1+ Bone Marrow‐derived Hepatocyte Stem Cells Transduced with Lentiviral‐mediated HGF Gene into CCl4‐injured Rats